1 year return (CAGR)
55.25%
Entera Bio Ltd Exchange (NASDAQ, USD)
ENTX
2.81
-0.17 (-5.70%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
62.08%
5 year return (CAGR)
-9.35%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
486.53M
Price/Sales
-
Ent value
487.43M
Price/Book
66.96
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-14.37%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.01 |
| Daily high | 3.01 |
| Daily low | 2.70 |
| Daily Volume | 858K |
| All-time high | 6.90 |
| 1y analyst estimate | 9.00 |
| Beta | 1.40 |
| EPS (TTM) | -0.34 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 27 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ENTX | S&P500 | |
| Current price drop from All-time high | -59.28% | -1.29% |
| Highest price drop | -92.75% | -56.47% |
| Date of highest drop | 11 Nov 2022 | 9 Mar 2009 |
| Avg drop from high | -65.47% | -10.68% |
| Avg time to new high | 331 days | 12 days |
| Max time to new high | 1390 days | 1805 days |
News
